[1]
|
Ajani J A, D'Amico T A, Bentrem D J, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(2):167-92. |
[2]
|
中华医学会外科学分会腹腔镜与内镜外科学组. Siewert Ⅱ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2023版)[J] 中华消化外科杂志. 2023, (07):799-809. |
[3]
|
陈凌, 刘凤林. 食管胃结合部腺癌的定义和分型:从历史到现状[J] 中华外科杂志. 2022, (09):813-8. |
[4]
|
Arnold M, Ferlay J, van Berge Henegouwen M I, et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018[J]. Gut, 2020, 69(9):1564-71. |
[5]
|
Xu H, Zhang L, Miao J, et al. Patterns of recurrence in adenocarcinoma of the esophagogastric junction:a retrospective study[J]. World J Surg Oncol, 2020, 18(1):144. |
[6]
|
Kang W-M, Meng Q-B, Yu J-C, et al. Factors associated with early recurrence after curative surgery for gastric cancer[J]. World J Gastroenterol, 2015, 21(19):5934-40. |
[7]
|
Zhao J, Zhao J, Du F, et al. Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection:a Large-Scale, Multicenter Study in China[J]. J Gastrointest Surg, 2016, 20(4):700-7. |
[8]
|
Feng Y, Jiang Y, Zhao Q, et al. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China:a seven-year study[J]. BMC Surg, 2020, 20(1):302. |
[9]
|
Yang Y, Huang X, Zhou L, et al. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma[J]. BMC Cancer, 2019, 19(1):526. |
[10]
|
Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer:a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association[J]. Gastric Cancer, 2014, 17(1):26-33. |
[11]
|
Jing R, Cui M, Ju S, et al. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer[J]. Clin Lab, 2020, 66(4). |
[12]
|
He K, Si L, Pan X, et al. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery[J]. Front Oncol, 2022, 12:829689. |
[13]
|
Riley R D, Ensor J, Snell K I E, et al. Calculating the sample size required for developing a clinical prediction model[J]. BMJ, 2020, 368:m441. |
[14]
|
Li S, Ying X, Shan F, et al. Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction:An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study)[J]. Chin J Cancer Res, 2022, 34(4):406-14. |
[15]
|
Guo Z, Guo H, Tian Y, et al. Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery[J]. Front Oncol, 2022, 12:908229. |
[16]
|
Gao Y, Xin L, Lin H, et al. Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction:a nationwide, multicohort, prospective study[J]. Lancet Gastroenterol Hepatol, 2023, 8(5):432-45. |
[17]
|
Takeda F R, Kodama Pertille Ramos M F, Pereira M A, et al. Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era[J]. Am J Surg, 2021, 221(3):631-6. |
[18]
|
赵龙, 蒋洪朋, 杨长江, 等. Siewert Ⅱ型和Ⅲ型食管胃结合部腺癌的临床病理特征及预后影响因素分析[J] 中华消化外科杂志. 2022, (12):1560-6. |
[19]
|
Al-Batran S-E, Goetze T O, Mueller D W, et al. The RENAISSANCE (AIO-FLOT5) trial:effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction-a phase III trial of the German AIO/CAO-V/CAOGI[J]. BMC Cancer, 2017, 17(1):893. |
[20]
|
Chen J, Xia Y-J, Liu T-Y, et al. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data[J]. BMC Cancer, 2021, 21(1):532. |
[21]
|
张克昌, 范林广, 王杰, 等. Siewert Ⅱ型和Ⅲ型食管胃结合部腺癌下纵隔淋巴结转移影响因素及转移规律分析[J] 中华消化外科杂志. 2022, (10):1370-5. |
[22]
|
Hedrick C C, Malanchi I. Neutrophils in cancer:heterogeneous and multifaceted[J]. Nat Rev Immunol, 2022, 22(3):173-87. |
[23]
|
De Meo M L, Spicer J D. The role of neutrophil extracellular traps in cancer progression and metastasis[J]. Semin Immunol, 2021, 57:101595. |
[24]
|
Szczerba B M, Castro-Giner F, Vetter M, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression[J]. Nature, 2019, 566(7745):553-7. |
[25]
|
Herre M, Cedervall J, Mackman N, et al. Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases[J]. Physiol Rev, 2023, 103(1):277-312. |
[26]
|
Man Y-G, Stojadinovic A, Mason J, et al. Tumor-infiltrating immune cells promoting tumor invasion and metastasis:existing theories[J]. J Cancer, 2013, 4(1):84-95. |
[27]
|
Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917):860-7. |
[28]
|
Rossi J-F, Lu Z Y, Massart C, et al. Dynamic Immune/Inflammation Precision Medicine:The Good and the Bad Inflammation in Infection and Cancer[J]. Front Immunol, 2021, 12:595722. |
[29]
|
Stotz M, Pichler M, Absenger G, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer[J]. Br J Cancer, 2014, 110(2):435-40. |
[30]
|
Wang Y, Hu X, Xu W, et al. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer:A retrospective study[J]. Thorac Cancer, 2019, 10(6):1402-11. |
[31]
|
Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis[J]. J Hematol Oncol, 2021, 14(1):173. |
[32]
|
于小鹏, 陈家璐, 唐玥, 等. 基于炎症相关指标术前预测肝内胆管癌淋巴结转移的列线图模型构建[J] 中华外科杂志. 2023, (04):321-9. |
[33]
|
Deng K, Yang L, Hu B, et al. The prognostic significance of pretreatment serum CEA levels in gastric cancer:a meta-analysis including 14651 patients[J]. PLoS One, 2015, 10(4):e0124151. |
[34]
|
Xiao Y, Zhang J, He X, et al. Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer:a meta-analysis[J]. Ir J Med Sci, 2014, 183(4):557-64. |